Cargando…
Molecular Biocompatibility of a Silver Nanoparticle Complex with Graphene Oxide to Human Skin in a 3D Epidermis In Vitro Model
Silver nanoparticles (AgNP) can migrate to tissues and cells of the body, as well as to agglomerate, which reduces the effectiveness of their use for the antimicrobial protection of the skin. Graphene oxide (GO), with a super-thin flake structure, can be a carrier of AgNP that stabilizes their movem...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319156/ https://www.ncbi.nlm.nih.gov/pubmed/35890292 http://dx.doi.org/10.3390/pharmaceutics14071398 |
_version_ | 1784755480814419968 |
---|---|
author | Zielińska-Górska, Marlena Sawosz, Ewa Sosnowska, Malwina Hotowy, Anna Grodzik, Marta Górski, Konrad Strojny-Cieślak, Barbara Wierzbicki, Mateusz Chwalibog, André |
author_facet | Zielińska-Górska, Marlena Sawosz, Ewa Sosnowska, Malwina Hotowy, Anna Grodzik, Marta Górski, Konrad Strojny-Cieślak, Barbara Wierzbicki, Mateusz Chwalibog, André |
author_sort | Zielińska-Górska, Marlena |
collection | PubMed |
description | Silver nanoparticles (AgNP) can migrate to tissues and cells of the body, as well as to agglomerate, which reduces the effectiveness of their use for the antimicrobial protection of the skin. Graphene oxide (GO), with a super-thin flake structure, can be a carrier of AgNP that stabilizes their movement without inhibiting their antibacterial properties. Considering that the human skin is often the first contact with antimicrobial agent, the aim of the study was to assess whether the application of the complex of AgNP and GO is biocompatible with the skin model in in vitro studies. The conducted tests were performed in accordance with the criteria set in OECD TG439. AgNP-GO complex did not influence the genotoxicity and metabolism of the tissue. Furthermore, the complex reduced the pro-inflammatory properties of AgNP by reducing expression of IP-10 (interferon gamma-induced protein 10), IL-3 (interleukin 3), and IL-4 (interleukin 4) as well as MIP1β (macrophage inflammatory protein 1β) expressed in the GO group. Moreover, it showed a positive effect on the micro- and ultra-structure of the skin model. In conclusion, the synergistic effect of AgNP and GO as a complex can activate the process of epidermis renewal, which makes it suitable for use as a material for skin contact. |
format | Online Article Text |
id | pubmed-9319156 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93191562022-07-27 Molecular Biocompatibility of a Silver Nanoparticle Complex with Graphene Oxide to Human Skin in a 3D Epidermis In Vitro Model Zielińska-Górska, Marlena Sawosz, Ewa Sosnowska, Malwina Hotowy, Anna Grodzik, Marta Górski, Konrad Strojny-Cieślak, Barbara Wierzbicki, Mateusz Chwalibog, André Pharmaceutics Article Silver nanoparticles (AgNP) can migrate to tissues and cells of the body, as well as to agglomerate, which reduces the effectiveness of their use for the antimicrobial protection of the skin. Graphene oxide (GO), with a super-thin flake structure, can be a carrier of AgNP that stabilizes their movement without inhibiting their antibacterial properties. Considering that the human skin is often the first contact with antimicrobial agent, the aim of the study was to assess whether the application of the complex of AgNP and GO is biocompatible with the skin model in in vitro studies. The conducted tests were performed in accordance with the criteria set in OECD TG439. AgNP-GO complex did not influence the genotoxicity and metabolism of the tissue. Furthermore, the complex reduced the pro-inflammatory properties of AgNP by reducing expression of IP-10 (interferon gamma-induced protein 10), IL-3 (interleukin 3), and IL-4 (interleukin 4) as well as MIP1β (macrophage inflammatory protein 1β) expressed in the GO group. Moreover, it showed a positive effect on the micro- and ultra-structure of the skin model. In conclusion, the synergistic effect of AgNP and GO as a complex can activate the process of epidermis renewal, which makes it suitable for use as a material for skin contact. MDPI 2022-07-01 /pmc/articles/PMC9319156/ /pubmed/35890292 http://dx.doi.org/10.3390/pharmaceutics14071398 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zielińska-Górska, Marlena Sawosz, Ewa Sosnowska, Malwina Hotowy, Anna Grodzik, Marta Górski, Konrad Strojny-Cieślak, Barbara Wierzbicki, Mateusz Chwalibog, André Molecular Biocompatibility of a Silver Nanoparticle Complex with Graphene Oxide to Human Skin in a 3D Epidermis In Vitro Model |
title | Molecular Biocompatibility of a Silver Nanoparticle Complex with Graphene Oxide to Human Skin in a 3D Epidermis In Vitro Model |
title_full | Molecular Biocompatibility of a Silver Nanoparticle Complex with Graphene Oxide to Human Skin in a 3D Epidermis In Vitro Model |
title_fullStr | Molecular Biocompatibility of a Silver Nanoparticle Complex with Graphene Oxide to Human Skin in a 3D Epidermis In Vitro Model |
title_full_unstemmed | Molecular Biocompatibility of a Silver Nanoparticle Complex with Graphene Oxide to Human Skin in a 3D Epidermis In Vitro Model |
title_short | Molecular Biocompatibility of a Silver Nanoparticle Complex with Graphene Oxide to Human Skin in a 3D Epidermis In Vitro Model |
title_sort | molecular biocompatibility of a silver nanoparticle complex with graphene oxide to human skin in a 3d epidermis in vitro model |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319156/ https://www.ncbi.nlm.nih.gov/pubmed/35890292 http://dx.doi.org/10.3390/pharmaceutics14071398 |
work_keys_str_mv | AT zielinskagorskamarlena molecularbiocompatibilityofasilvernanoparticlecomplexwithgrapheneoxidetohumanskinina3depidermisinvitromodel AT sawoszewa molecularbiocompatibilityofasilvernanoparticlecomplexwithgrapheneoxidetohumanskinina3depidermisinvitromodel AT sosnowskamalwina molecularbiocompatibilityofasilvernanoparticlecomplexwithgrapheneoxidetohumanskinina3depidermisinvitromodel AT hotowyanna molecularbiocompatibilityofasilvernanoparticlecomplexwithgrapheneoxidetohumanskinina3depidermisinvitromodel AT grodzikmarta molecularbiocompatibilityofasilvernanoparticlecomplexwithgrapheneoxidetohumanskinina3depidermisinvitromodel AT gorskikonrad molecularbiocompatibilityofasilvernanoparticlecomplexwithgrapheneoxidetohumanskinina3depidermisinvitromodel AT strojnycieslakbarbara molecularbiocompatibilityofasilvernanoparticlecomplexwithgrapheneoxidetohumanskinina3depidermisinvitromodel AT wierzbickimateusz molecularbiocompatibilityofasilvernanoparticlecomplexwithgrapheneoxidetohumanskinina3depidermisinvitromodel AT chwalibogandre molecularbiocompatibilityofasilvernanoparticlecomplexwithgrapheneoxidetohumanskinina3depidermisinvitromodel |